N-(5-Hydroxynaphthalen-1-yl)biphenyl-4-sulfonamide

ID: ALA3360264

PubChem CID: 56941135

Max Phase: Preclinical

Molecular Formula: C22H17NO3S

Molecular Weight: 375.45

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=S(=O)(Nc1cccc2c(O)cccc12)c1ccc(-c2ccccc2)cc1

Standard InChI:  InChI=1S/C22H17NO3S/c24-22-11-5-8-19-20(22)9-4-10-21(19)23-27(25,26)18-14-12-17(13-15-18)16-6-2-1-3-7-16/h1-15,23-24H

Standard InChI Key:  VOVUNCRLXUULCK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    3.0707   -5.4933    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4834   -6.2032    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.8918   -5.4909    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7776   -6.6159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1930   -6.6159    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9007   -6.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0678   -6.2082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3625   -6.6202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3666   -7.4387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0819   -7.8433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7842   -7.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3148   -5.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6021   -4.9859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8978   -5.3962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6650   -7.8508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0532   -7.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7521   -7.8582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7490   -8.6762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0365   -9.0797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6719   -8.6646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3144   -6.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6086   -6.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6084   -7.4311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3133   -7.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0198   -7.4272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0165   -6.6161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7230   -6.2054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  2  1  0
  2  5  1  0
  5  6  1  0
  4  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  4  1  0
  6 22  2  0
 21 12  2  0
 12 13  1  0
 13 14  2  0
 14  6  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  9 15  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
M  END

Alternative Forms

Associated Targets(Human)

UQCRB Tbio Cytochrome b-c1 complex subunit 7 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 375.45Molecular Weight (Monoisotopic): 375.0929AlogP: 5.01#Rotatable Bonds: 4
Polar Surface Area: 66.40Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.54CX Basic pKa: CX LogP: 4.79CX LogD: 4.59
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -0.82

References

1. Jung HJ, Cho M, Kim Y, Han G, Kwon HJ..  (2014)  Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads.,  57  (19): [PMID:25244355] [10.1021/jm500863j]
2. Choi E, Lee J, Lee S, Song BW, Seo HH, Cha MJ, Lim S, Lee C, Song SW, Han G, Hwang KC..  (2016)  Potential therapeutic application of small molecule with sulfonamide for chondrogenic differentiation and articular cartilage repair.,  26  (20): [PMID:27614412] [10.1016/j.bmcl.2016.08.069]

Source